Nuclear factor kappa B signaling in catabolic disorders

被引:16
作者
Holmes-McNary, M [1 ]
机构
[1] Ohio State Univ, Coll Human Ecol & Med, Dept Human Nutr, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1097/00075197-200205000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nuclear factor kappaB family of inducible transcription factors regulates the expression of many genes. Nuclear factor kappaB has been implicated in autoimmune and inflammatory diseases, infection, cell survival, and cell transformation with subsequent promotion of cancer. In this review, we summarize features of nuclear factor kappaB regulation in several catabolic disorders, and describe its role in normal cellular function as well as provide an important link to the role of scaffold proteins, cellular receptors, and other cell signaling pathway kinases that converge on the nuclear factor kappaB signaling cascade. Subsequently, we focus on the role of nuclear factor kappaB in cell survival and oxidative stress. Finally, potential therapeutic strategies are discussed that may modify nuclear factor kappaB activity including endogenous antioxidant systems and the Fas/FasL system. However, challenges still remain in developing new therapeutic strategies that not only include identifying novel agents, but also by improving clinical endpoint definitions and by defining biological efficacy. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 57 条
[1]   Cross-talk between pro-inflammatory transcription factors and glucocorticoids [J].
Adcock, IM ;
Caramori, G .
IMMUNOLOGY AND CELL BIOLOGY, 2001, 79 (04) :376-384
[2]   The role of Fas-mediated apoptosis in thyroid disease [J].
Andrikoula, M ;
Tsatsoulis, A .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (06) :561-568
[3]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[4]   NFκB interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription [J].
Bing, ZY ;
Huang, JYH ;
Liao, WSL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :31616-31623
[5]   The nuclear factor kappa B (NF-κB):: A potential therapeutic target for estrogen receptor negative breast cancers [J].
Biswas, DK ;
Dai, SC ;
Cruz, A ;
Weiser, B ;
Graner, E ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10386-10391
[6]   NF-κB mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1β [J].
Brouillard, F ;
Bouthier, M ;
Leclerc, T ;
Clement, A ;
Baudouin-Legros, M ;
Edelman, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :9486-9491
[7]   NF-κB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1β [J].
Cafferata, EGA ;
Guerrico, AMG ;
Pivetta, OH ;
Santa-Coloma, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :15441-15444
[8]   Activation of apoptosis signal regulating kinase 1 (ASK1) by the adapter protein Daxx [J].
Chang, HY ;
Nishitoh, H ;
Yang, XL ;
Ichijo, H ;
Baltimore, D .
SCIENCE, 1998, 281 (5384) :1860-1863
[9]   Impairment by interleukin 1 beta and tumour necrosis factor a of the glucagon-induced increase in phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis in cultured rat hepatocytes [J].
Christ, B ;
Nath, A .
BIOCHEMICAL JOURNAL, 1996, 320 :161-166
[10]   Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3 [J].
Cogswell, PC ;
Guttridge, DC ;
Funkhouser, WK ;
Baldwin, AS .
ONCOGENE, 2000, 19 (09) :1123-1131